Rigel Pharmaceuticals (RIGL) Posts Wider than Expected Q4 Loss of 36c/Share
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $42.45 -0.31%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q4 EPS of ($0.36), $0.08 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- RBC Capital Downgrades Hermes International (RMS:FP) (HESAY) to Sector Perform
- Rigel Pharmaceuticals (RIGL) PT Raised to $49 at Piper Sandler
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
